Search results
Results From The WOW.Com Content Network
The company is the second largest in the institutional pharmacy services market, with revenues of $1.9 billion and a customer base of 330,000 "beds" in 41 U.S. states. In August 2011, pharmacy services provider Omnicare made a bid of $457 million for all outstanding shares of PharMerica.
The 10-second takeaway For the quarter ended March 31 (Q1), PharMerica beat slightly on revenues and beat expectations on earnings per share. Compared to PharMerica Beats on Both Top and Bottom Lines
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares ...
The 10-second takeaway For the quarter ended Sep. 30 (Q3), PharMerica met expectations on revenues and beat expectations on earnings per share. Compared PharMerica Beats Analyst Estimates on EPS
The Dow Jones Industrial Average, an American stock index composed of 30 large companies, has changed its components 59 times since its inception, on May 26, 1896. [1] As this is a historical listing, the names here are the full legal name of the corporation on that date, with abbreviations and punctuation according to the corporation's own usage.
Will be right back... Thank you for your patience. Our engineers are working quickly to resolve the issue.
PharMerica (NYS: PMC) is expected to report Q1 earnings on May 1. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average ...
The New York Stock Exchange Building on September 1, 2011, with an Omnicare banner marking the 30th anniversary of the company's public listing. Omnicare, Inc. is an American company working in the health-care industry. It was established in April 1981 as a spinoff of healthcare businesses from Chemed and W. R. Grace and Company.